Australian multicentre study of current real-world prophylaxis practice in severe and moderate haemophilia A and B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Australian multicentre study of current real-world prophylaxis practice in severe and moderate haemophilia A and B

Published:2018-01-03 Issue:2 Volume:24 Page:253-260
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Mason J. A.¹²,Parikh S.¹,Tran H.¹³⁴,Rowell J.¹²,McRae S.¹²⁵^ORCID

Affiliation:

1. Australian Haemophilia Centre Directors Organisation (AHCDO); Melbourne Vic. Australia

2. Queensland Haemophilia Centre; Royal Brisbane and Women's Hospital; Brisbane QLD Australia

3. Ronald Sawyers Haemophilia Centre; The Alfred Hospital; Melbourne Vic. Australia

4. Australian Centre for Blood Diseases; Monash University; Melbourne Vic. Australia

5. Department of Haematology; South Australia Pathology; Royal Adelaide Hospital; Adelaide SA Australia

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13375/fullpdf

Reference24 articles.

1. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study);Gringeri;J Thromb Haemost,2011

2. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N Engl J Med,2007

3. Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study;Collins;J Thromb Haemost,2010

4. Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs;Tagliaferri;Thromb Haemost,2006

5. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH;Fischer;J Thromb Haemost,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A post hoc comparative real‐world analysis of HEAD‐US score for joint health assessment of patients with severe haemophilia A and B in Spain;Haemophilia;2024-01-28

2. Evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half‐life (EHL) factor products: A 12‐month data analysis;Haemophilia;2023-08-11

3. Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature;Haemophilia;2022-10-12

4. Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe;Orphanet Journal of Rare Diseases;2021-12

5. Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria;Scientific Reports;2021-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3